Tang Jing, Li Yi-Min, Wang Yan, Yan Feng, Feng Zhao, Lv Rui-Hua, Gao Jing, Peng Liang, Hu Xiao-Chen, Zhang Gang
Key Laboratory for Research and Development of "Qin Medicine" of Shaanxi Administration of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Xi'an 712046, China; College of Pharmacy and Shaanxi Qinling Application Development and Engineering Center of Chinese Herbal Medicine, Shaanxi University of Chinese Medicine, Xi'an 712046, China; State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi University of Chinese Medicine, Xianyang 712083, China.
Key Laboratory for Research and Development of "Qin Medicine" of Shaanxi Administration of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Xi'an 712046, China; College of Pharmacy and Shaanxi Qinling Application Development and Engineering Center of Chinese Herbal Medicine, Shaanxi University of Chinese Medicine, Xi'an 712046, China.
Genomics. 2024 Nov;116(6):110948. doi: 10.1016/j.ygeno.2024.110948. Epub 2024 Oct 9.
Rhubarb is a traditional medicinal plant in China, whose pharmacological effects derive mainly from its anthraquinones. However, the regulatory mechanism affecting anthraquinone biosynthesis in R. officinale remains poorly understood. We assembled a high-quality, full-length transcriptome using single-molecule real-time (SMRT) sequencing. 274 unigenes potentially involved in the biosynthesis of anthraquinones, including those in the shikimate, polyketide, MVA and MEP pathways, were identified based on full-length transcriptome. Differentially expressed genes (DEGs) induced by MeJA treatment and DEGs between different tissues were identified through next-generation sequencing (NGS), revealing the genes that may be involved in the biosynthesis of anthraquinones. The basic leucine zipper (bZIP) transcription factors of R. officinale were systematically identified. Key genes such as RobZIP50 and RobZIP53 were systematically identified and found to be associated with anthraquinone biosynthesis in R. officinale through differential expression, co-expression and protein interaction analyses. RobZIP50 and RobZIP53 were highly expressed in roots and rhizomes, and significantly increased after 12 h of MeJA treatment. Additionally, both RobZIP50 and RobZIP53 were localized exclusively in the nucleus, with RobZIP53 showing significant transcriptional activity. Taken together, our results suggest that RobZIP53 may play a role in regulating anthraquinone biosynthesis in R. officinale.
大黄是中国的一种传统药用植物,其药理作用主要源于其蒽醌类化合物。然而,影响药用大黄中蒽醌生物合成的调控机制仍知之甚少。我们使用单分子实时(SMRT)测序组装了一个高质量的全长转录组。基于全长转录组,鉴定出274个可能参与蒽醌生物合成的单基因,包括莽草酸途径、聚酮途径、甲羟戊酸途径和2-C-甲基-D-赤藓糖醇-4-磷酸途径中的那些基因。通过下一代测序(NGS)鉴定了茉莉酸甲酯(MeJA)处理诱导的差异表达基因(DEG)以及不同组织之间的DEG,揭示了可能参与蒽醌生物合成的基因。对药用大黄的碱性亮氨酸拉链(bZIP)转录因子进行了系统鉴定。通过差异表达、共表达和蛋白质相互作用分析,系统鉴定出关键基因如RobZIP50和RobZIP53,并发现它们与药用大黄中蒽醌的生物合成有关。RobZIP50和RobZIP53在根和根茎中高表达,在MeJA处理12小时后显著增加。此外,RobZIP50和RobZIP53都仅定位于细胞核,其中RobZIP53表现出显著的转录活性。综上所述,我们的结果表明RobZIP53可能在调控药用大黄中蒽醌的生物合成中发挥作用。